|
Management of myasthenia gravis during pregnancy
Ramandeep Bansal1, Manoj Kumar Goyal2, Manish Modi2
1 Advanced Skin and Medicine Clinic, Chandigarh, India
2 Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Correspondence Address:
Dr. Manish Modi
Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
India
The management of myasthenia gravis (MG) during pregnancy requires special skills as both diseases as well as its treatment can have deleterious effects on mother and fetus. MG often affects women in second and third decades of life during the childbearing age. Exacerbations of MG are likely to occur during the first trimester and postpartum period. The treatment of MG during pregnancy needs to be individualized depending on the severity of MG as well as the efficacy of various treatment modalities and their possible harmful effects on pregnancy. In addition, special attention has to be given to avoid drugs and other factors (such as urinary tract infections) which may worsen MG. The key to successful outcome during pregnancy in myasthenic women lies in multidisciplinary care involving obstetricians, neurologists, anesthetist as well as neonatologist. In this review, we discuss various therapeutic options available for the management of MG during pregnancy and provide recommendations based on the current best evidence.
How to cite this article:
Bansal R, Goyal MK, Modi M. Management of myasthenia gravis during pregnancy.Indian J Pharmacol 2018;50:302-308
|
How to cite this URL:
Bansal R, Goyal MK, Modi M. Management of myasthenia gravis during pregnancy. Indian J Pharmacol [serial online] 2018 [cited 2023 Mar 29 ];50:302-308
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2018;volume=50;issue=6;spage=302;epage=308;aulast=Bansal;type=0 |
|
